Leukemias, lymphomas, and other hematologic cancers
Drug Name
- “Real-World” Hospitalization Data on Patients Receiving CAR-T Cell Therapy
- ADCETRIS
- ALIQOPA
- ALKERAN
- ALKERAN FOR INJECTION
- ARRANON
- ARZERRA
- BELEODAQ
- BENDEKA
- BESPONSA
- BEXXAR
- BICNU
- Bleomycin
- BLINCYTO
- BMT Societies Issue Recommendations on Posttransplant Maintenance in HL/NHL
- BOSULIF
- BUSULFEX
- CALQUENCE
- CAMPATH
- Carfilzomib Dosing and Scheduling in Newly Diagnosed Multiple Myeloma
- CERUBIDINE
- Cladribine
- CLOLAR
- clonoSEQ and MRD Testing in Multiple Myeloma and ALL
- Comparing Efficacy and Safety of Auto-HCT in Older and Younger Patients With Multiple Myeloma
- COPIKTRA
- Cure Rate Disparities Among Children With Burkitt Lymphoma
- Cyclophosphamide
- Cyclophosphamide Injection
- Cytarabine
- Dacarbazine
- DACOGEN
- DARZALEX
- DAURISMO
- Deep Analysis of BCR-ABL Transcripts Predicts Tyrosine Kinase Inhibitor Response in CML
- DEPOCYT
- Designing a Clinical Trial to Evaluate Multistage Treatment Approaches in CLL
- Disease Progression Is Associated With Increased Costs for Patients With Hematologic Malignancies
- DOXIL
- Doxorubicin HCl
- Doxorubicin HCl Solution
- EMPLICITI
- ERWINAZE
- EVOMELA
- FARYDAK
- Fludarabine
- FOLOTYN
- GAZYVA
- GLEEVEC
- GLEOSTINE
- HYDREA
- ICLUSIG
- IDAMYCIN PFS
- Idarubicin
- IDHIFA
- IMBRUVICA
- IMBRUVICA TABLETS
- INTRON A
- INTRON A SOLN
- ISTODAX
- JAKAFI
- KEYTRUDA
- KYMRIAH
- KYPROLIS
- Lack of Thromboprophylactic Benefit With Rivaroxaban in Ambulatory Patients With Cancer
- LEUKERAN
- LUMOXITI
- MARQIBO
- MATULANE
- MEK Inhibition Spurs Durable Responses in Patients With Histiocytic Neoplasms
- Mercaptopurine
- Methotrexate for injection
- Methotrexate injection
- Mitoxantrone HCl
- Molecular Characterization of Pediatric Follicular Lymphoma
- MUSTARGEN
- Myeloma Trial Aims to Use Genetic Profile for Treatment Optimization
- MYLERAN
- NINLARO
- ONCASPAR
- ONTAK
- OPDIVO
- Overall Survival in Follicular Lymphoma With Complete Response Similar to General Population
- Pamidronate disodium Injection
- Pentostatin
- POMALYST
- POTELIGEO
- PURIXAN
- REVLIMID
- RITUXAN
- RITUXAN HYCELA
- RYDAPT
- Second Patient Achieves Sustained HIV-1 Remission After Treatment Cessation
- SOX11 Status Not an Independent Prognostic Factor in Mantle Cell Lymphoma
- SPRYCEL
- Sustained Efficacy and Safety of Ibrutinib in Relapsed/Refractory CLL
- SYNRIBO
- TARGRETIN
- TARGRETIN GEL
- TASIGNA
- Teniposide
- Textured Implants at Sites Other Than the Breast May Increase Risk of Implant-Associated ALCL
- THALOMID
- Thioguanine
- TIBSOVO
- TREANDA
- Treatment of Early FL More Effective With PET-Staging and Contemporary RT
- Tretinoin Capsules
- TREXALL
- TRISENOX
- UVADEX
- VALCHLOR
- VELCADE
- VENCLEXTA
- VIDAZA
- Vinblastine for injection
- Vinblastine injection
- Vincristine Sulfate PFS
- VYXEOS
- XATMEP
- XOSPATA
- YESCARTA
- ZELBORAF
- ZEVALIN
- ZOLINZA
- ZOMETA
- ZYDELIG
